Trial Profile

Dupilumab in the Treatment of Alopecia Areata Patients With an Atopic Background and/or High IgE

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 25 Jun 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dupilumab (Primary)
Indications Alopecia areata
Focus Therapeutic Use

Most Recent Events

17 Jun 2026 Planned number of patients changed from 68 to 76.
17 Jun 2026 Planned End Date changed from 3 Nov 2027 to 31 Oct 2028.
17 Jun 2026 Planned primary completion date changed from 3 Nov 2027 to 30 Nov 2027.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com